Concentration of MitoQ in Human Skeletal Muscle

Healthy Clinical Trial

— MitoQ/muscle  

Official title:

Concentration of Mitoquinone Mesylate in Skeletal Muscle After a Single Oral Dose of MitoQ

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04098510
• Other study ID #: MitoQ
• Status: Recruiting
• Phase: N/A
• Start date: September 8, 2019
• Est. completion date: September 30, 2020

Study information

• Verified date: September 2019
• Source: University of Copenhagen
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine mitoquinone mesylate concentration levels in skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10
• Est. completion date: September 30, 2020
• Est. primary completion date: September 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Healthy,

• Male

• 18-40 years of age

Exclusion Criteria:

• Previous use of MitoQ or CoQ-10 within 30 days of screening appointment

• Ongoing use of MitoQ

• Smoking

• Ongoing treatment with medications

• Disease deemed by the MD to infer a risk to participate in the trial

Related Conditions & MeSH terms

• Healthy

Intervention

Dietary Supplement:
• MitoQ
Subjects ingest 8x20 mg MitoQ capsules

Locations

Country	Name	City	State
Denmark	August Krogh Building	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
University of Copenhagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Muscle mitoquinone mesylate concentration	Concentration of mitoquinone mesylate in skeletal muscle	Before oral administration of MitoQ
Primary	Muscle mitoquinone mesylate concentration	Concentration of mitoquinone mesylate in skeletal muscle	1 hours after oral administration of MitoQ
Primary	Muscle mitoquinone mesylate concentration	Concentration of mitoquinone mesylate in skeletal muscle	3 hours after oral administration of MitoQ
Primary	Muscle mitoquinone mesylate concentration	Concentration of mitoquinone mesylate in skeletal muscle	5 hours after oral administration of MitoQ
Secondary	Blood mitoquinone mesylate concentration	Concentration of mitoquinone mesylate in venous blood	Before as well as 0.5, 1, 1.5, 2, 3, 4 and 5 hours after oral administration of MitoQ